These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Is misoprostol effective in NSAID-induced gastrointestinal complications?]. Stucki G; Sangha O; Michel BA Schweiz Med Wochenschr; 1996 Sep; 126(37):1573-8. PubMed ID: 8927962 [TBL] [Abstract][Full Text] [Related]
5. Misoprostol for the treatment of peptic ulcer and antiinflammatory-drug-induced gastroduodenal ulceration. Walt RP N Engl J Med; 1992 Nov; 327(22):1575-80. PubMed ID: 1435885 [No Abstract] [Full Text] [Related]
6. Review article: prevention of non-steroidal anti-inflammatory drug gastrointestinal complications--review and recommendations based on risk assessment. Chan FK; Graham DY Aliment Pharmacol Ther; 2004 May; 19(10):1051-61. PubMed ID: 15142194 [TBL] [Abstract][Full Text] [Related]
7. Prevention of gastroduodenal injury induced by NSAIDs with low-dose misoprostol. Medina Santillán R; Reyes García G; Mateos García E Proc West Pharmacol Soc; 1999; 42():33-4. PubMed ID: 10697681 [No Abstract] [Full Text] [Related]
8. [Present position in the prevention and therapy of NSAID-induced ulcers]. Lehmann FS; Beglinger C Schweiz Med Wochenschr; 1999 Jul; 129(29-30):1073-80. PubMed ID: 10464910 [TBL] [Abstract][Full Text] [Related]
9. [Misoprostol in the prevention of gastric erosions caused by nonsteroidal anti-inflammatory agents]. Delmas PD; Lambert R; Capron MH Rev Rhum Ed Fr; 1994 Feb; 61(2):126-31. PubMed ID: 7920500 [TBL] [Abstract][Full Text] [Related]
10. Misoprostol and NSAID ulcers. Isaacs P Am J Gastroenterol; 1996 Feb; 91(2):187-8. PubMed ID: 8607480 [No Abstract] [Full Text] [Related]
11. Prevention of non-steroidal anti-inflammatory drug-induced gastrointestinal mucosal injury: risk factors for serious complications. Koch M; Dezi A; Tarquini M; Capurso L Dig Liver Dis; 2000 Mar; 32(2):138-51. PubMed ID: 10975790 [TBL] [Abstract][Full Text] [Related]
12. Misoprostol and ranitidine in the prevention of NSAID-induced ulcers: a prospective, double-blind, multicenter study. Raskin JB; White RH; Jaszewski R; Korsten MA; Schubert TT; Fort JG Am J Gastroenterol; 1996 Feb; 91(2):223-7. PubMed ID: 8607484 [TBL] [Abstract][Full Text] [Related]
13. [Prevention of NSAID-induced gastric lesions: H2 antagonists or misoprostol? A meta-analysis of controlled clinical studies]. Capurso L; Koch M Clin Ter; 1991 Dec 15-31; 139(5-6):179-89. PubMed ID: 1686995 [No Abstract] [Full Text] [Related]
14. NSAIDs: a pain in the gut. Abraham P; Bhatia SJ J Assoc Physicians India; 1991 Dec; 39(12):915-7. PubMed ID: 1816215 [No Abstract] [Full Text] [Related]
15. Does famotidine have similar efficacy to misoprostol in the treatment of non-steroidal anti-inflammatory drug-induced gastropathy? Wu CS; Wang SH; Chen PC; Wu VC Int J Clin Pract; 1998 Oct; 52(7):472-4. PubMed ID: 10622088 [TBL] [Abstract][Full Text] [Related]
16. New drug to prevent NSAID-related ulcers. Liss GM CMAJ; 1996 Oct; 155(8):1043. PubMed ID: 8873631 [No Abstract] [Full Text] [Related]
17. Non-steroidal anti-inflammatory drug gastropathy: clinical results with misoprostol. Koch M Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S54-62. PubMed ID: 10379471 [TBL] [Abstract][Full Text] [Related]
18. [Nonsteroidal antiinflammatory drugs and duodenal ulceration]. Shi GY Zhonghua Nei Ke Za Zhi; 1993 Aug; 32(8):511-2. PubMed ID: 8269778 [No Abstract] [Full Text] [Related]